What is the NOAEL for 2-Hydroxy-4-methoxybenzophenone?
2-Hydroxy-4-methoxybenzophenone has 100 NOAEL studies in the database. The lowest reported value is -3 mg/kg bw/day. Source: UnifiedCodex:SCCS_SHADOW:beta.noael_studies.
Also known as: BRN 1913145, EINECS 205-031-5, NCI-C60957, NSC-7778, Oxibenzonum (+4 more)
CAS 131-57-7
2-Hydroxy-4-methoxybenzophenone (CAS 131-57-7) is a chemical substance. Key regulatory status: REACH registered, 16 regulatory/inventory lists, cosmetic ingredient cross-reference; source data from EPA ToxValDB, EPA CPDat, AICIS, SCCS, ECHA REACH.
View cosmetic safety profile for Benzophenone-3 (Oxybenzone) →
CAS, identifiers, formula, and alternate names for the matched substance record.
Industrial and product-use categories associated with this substance.
Inventory, screening, and regulatory list matches from public chemical databases.
| List | Keyword | Source |
|---|---|---|
| Cleaning products and household care - shoes; Europe | Danish Environmental Protection Agency | Danish EPA |
| drinking_water; Europe; manufacturing; plastic_additive | Belgaqua | CPCat |
| Europe; Personal care | Danish Environmental Protection Agency | Danish EPA |
| Europe; Personal care | Danish Environmental Protection Agency | Danish EPA |
| Europe; Food contact items | Danish Environmental Protection Agency | Danish EPA |
| Europe; restricted | Danish Environmental Protection Agency | Danish EPA |
| IFRA Transparency | IFRA | IFRA |
| Cleaning products and household care - shoes; Europe | Danish Environmental Protection Agency | Danish EPA |
| inert_ingredient; non_food_use; Pesticides | EPA | CPCat |
| active_ingredient; Australia | Australian Pesticides and Veterinary Medicines Authority | CPCat |
| pharmaceutical | US International Trade Commission | CPCat |
| Indirect additives food contact (10/2018) | FDA | United States Food and Drug Administration (FDA) |
| detected; Europe; Personal care - nails - nail polish | Danish Environmental Protection Agency | Danish EPA |
| Canada; pharmaceutical | DrugBank | DrugBank |
| Canada; pharmaceutical | DrugBank | DrugBank |
| Europe; Personal care | European Commission | CosIng |
Toxicology endpoints rendered from public NOAEL study rows.
| Value | Unit | Endpoint | Route | Species | Source |
|---|---|---|---|---|---|
| -3 | - | - | - | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| -3 | - | - | - | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| -3 | - | - | - | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| -3 | - | - | - | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| -3 | - | - | - | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| -3 | - | - | - | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 0.5 | % | - | - | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 0.5 | % | - | - | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 1 | - | - | - | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 2 | - | - | - | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 3 | - | - | - | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 3 | - | - | - | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 3.2 | - | - | - | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 3.2 | - | - | - | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 3.2 | - | - | - | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 5 | - | - | - | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 6 | - | - | oral | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 6 | % | - | - | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 6 | % | - | - | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 6 | % | - | - | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 6 | % | - | - | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 6 | % | - | - | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 6 | % | - | - | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 6 | % | - | - | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 6 | % | - | - | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 8 | - | - | - | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 9 | - | - | - | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 9 | - | - | - | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 9 | - | - | - | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 10 | % | - | - | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 10 | % | - | - | rat | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 13 | - | - | - | rat | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 25 | - | - | - | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 25 | - | - | - | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 25 | - | - | - | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 30 | % | - | - | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 35 | - | - | oral | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 36 | - | - | - | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 36 | - | - | - | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 56 | - | - | - | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 56 | - | - | - | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 62 | - | - | - | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 67 | - | - | - | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 67.9 | mg/kg bw/d | - | oral | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 67.9 | mg/kg bw/d | - | oral | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 67.9 | mg/kg bw/d | - | oral | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 73 | - | - | - | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 97 | - | - | - | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 97 | - | - | - | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 97 | - | - | - | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
Showing 50 of 100 studies
Registration status from the ECHA REACH registered substances database.
| Status | Name | EC Number | Link |
|---|---|---|---|
| Registered | Oxybenzone | 205-031-5 | ECHA overview → |
Australian industrial chemicals inventory status and applicable conditions.
EU Scientific Committee opinions tied to the matched substance.
| Opinion | Date | Conclusion | Max Conc. | Concerns |
|---|---|---|---|---|
| SCCS/1625/20 | 30-31 March 2021 | safe with restrictions | 6% in face cream, hand cream, lipstick; 2.2% in body cream and spray products; 0.5% as product formulation protectant | Potential endocrine disrupting properties; systemic absorption concerns at full-body application; photostability concerns; restricted due to insufficient MoS for body application |
| SCCP/1201/08 | 16 December 2008 | safe with restrictions | up to 6% as UV filter; up to 0.5% as product protectant | Data insufficient to calculate MoS in 2006 opinion (SCCP/0998/06); revised opinion with new absorption data confirmed safe at 6% with specific product restrictions; estrogenic activity concerns |
| SCCP/0998/06 | 19 December 2006 | insufficient data (first submission; data gap) | No safe concentration established in this opinion; 6% was queried | Dermal absorption data insufficient; MoS could not be calculated; estrogenic activity concerns noted |
Same-CAS cosmetic ingredient record for cross-vertical context.
Same-CAS pharmaceutical records from drug and bioactivity sources.
2-Hydroxy-4-methoxybenzophenone has 100 NOAEL studies in the database. The lowest reported value is -3 mg/kg bw/day. Source: UnifiedCodex:SCCS_SHADOW:beta.noael_studies.
2-Hydroxy-4-methoxybenzophenone appears on 12 regulatory/inventory lists including Cleaning products and household care - shoes; Europe, drinking_water; Europe; manufacturing; plastic_additive, Europe; Personal care, and 9 more. Source: EPA CPDat.
Yes, 2-Hydroxy-4-methoxybenzophenone is also indexed as a cosmetic ingredient under the name Benzophenone-3 (Oxybenzone). View the full cosmetic safety profile on the ingredient page for detailed safety data, SCCS opinions, and regulatory status.
Safety data is sourced from EPA ToxValDB, EPA CPDat, AICIS (Australian Industrial Chemicals Introduction Scheme), EPA DSSTox, ECHA REACH, CosIng / Ingredients DB, ChEMBL / DailyMed. All data traces to primary regulatory sources and is updated from official government databases.
2-Hydroxy-4-methoxybenzophenone also appears in cosmetics, pharmaceutical databases.